-
-
-
-
-
-
-
Lexicon Announces Full Exercise and Closing of Options to Purchase Additional Shares in Connection with Previously Announced Public Offering and Concurrent Private Placement
-
-
-
-
-
-
-
Form 8-K LEXICON PHARMACEUTICALS, For: Mar 10
-
-
-
-
-
-
-
Lexicon Pharma (LXRX) Reports Positive 52-Week Results from Sotagliflozin in Tandem2 Study
-
-
-
-
-
-
-
Lexicon Pharmaceuticals (LXRX) Files To Sell Up To $150M
55,445 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All